Temodar Oral Capsule 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

TEMODAR: Oral capsule (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
TEMODAR 100mg Cap
Drug Image file default-drug-image.png
TEMODAR 100mg Cap
Drug Image file default-drug-image.png
TEMODAR 100mg Cap
Drug Image file default-drug-image.png
TEMODAR 100mg Cap

What is this Medicine?

TEMOZOLOMIDE (te moe ZOE loe mide) is a chemotherapy drug. It is used to treat some kinds of brain cancer.

CVS Pharmacy Patient Statistics for TEMODAR: Oral capsule(100mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

TEMODAR 100mg Capsule

NDC: 000851366
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Glioblastoma Multiforme, Astrocytoma

Sometimes used for but not FDA approved for the following conditions:
Malignant Melanoma, Malignant Glioma

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
TEMODAR 100mg Capsule

Reported Side Effects for TEMODAR 100mg Capsule

Lung Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Pulmonary Fibrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Dry Skin Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
<6.0%*
Severity: SEVERE
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Memory Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Fluid Retention Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Constipation Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Difficulty Swallowing Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: EARLY
Mouth Ulcers Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Blurred Vision Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Confusion Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: EARLY
Itching Incidence:
1.0%*
Severity: SEVERE
Onset: RAPID
Lightheadedness Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Nervousness Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Redness Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: EARLY
Decreased Appetite Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Paresthesias Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Upset Stomach Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: EARLY
Incoordination Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Headache Incidence:
2.0-6.0%*
Severity: SEVERE
Onset: EARLY
Uncontrolled Urination Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Fever Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Back Pain Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Drowsiness Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Paresis Incidence:
3.0-6.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
4.0-9.0%*
Severity: SEVERE
Onset: EARLY
Loss Of Memory Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Inability To Sleep Incidence:
4.0-10.0%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
4.0-14.0%*
Severity: SEVERE
Onset: DELAYED
Visual Impairment Incidence:
5.0%*
Severity: SEVERE
Onset: EARLY
Muscle Pain Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
5.0-6.0%*
Severity: MILD
Onset: EARLY
Weight Gain Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Double Vision Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Increased Urination Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Breast Pain Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
6.0-11.0%*
Severity: MILD
Onset: DELAYED
Convulsions Incidence:
6.0-23.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
8.0-14.0%*
Severity: SEVERE
Onset: DELAYED
Sore Throat Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Cushing's Syndrome Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Low Lymphocytes Incidence:
55.0%*
Severity: SEVERE
Onset: DELAYED
Hair Loss Incidence:
55.0-69.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with TEMODAR

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5